Clinical Trial Update: Comparison of Ipilimumab Manufactured by 2 Different Processes in Participants With Advanced Melanoma [Phase 1]

View source ↗

Summary

A Phase 1 study comparing ipilimumab produced by two different manufacturing processes in participants with advanced melanoma; results were posted in 2014.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Melanoma

Drugs mentioned

• ipilimumab (ipilimumab)

Snippet

Sponsor: Bristol-Myers Squibb | Conditions: Advanced Melanoma | Phase 1 | Status: COMPLETED | Results posted: 2014-03-06